Newsroom
Nearly $4 Million In Research Funding For Promising New Treatments In Alzheimer’s And Other Dementia
The Alzheimer’s Association and the Rainwater Charitable Foundation have joined forces again to fund drug discovery research towards finding therapies for Alzheimer’s disease.
Partnership Awards $3 Million in Grants for Promising New Treatments in Alzheimer’s and Related Dementias
$3 million in newly-awarded research grants give researchers across the country the ability to investigate creative new ways to target abnormal tau, a toxic brain protein that is a hallmark of Alzheimer’s disease, frontotemporal dementia, and many other neurodegenerative disorders.
BHA-CS: A novel cognitive composite for Alzheimer’s disease and related disorders
Nearly $4 Million In Research Funding For Promising New Treatments In Alzheimer’s And Other Dementia
The Alzheimer’s Association and the Rainwater Charitable Foundation have joined forces again to fund drug discovery research towards finding therapies for Alzheimer’s disease.
Microglial microRNAs mediate sex-specific responses to tau pathology
EuroTau to Host 2021 Rainwater Prize Events
The Rainwater Prize, a program of the Rainwater Charitable Foundation, is a sponsor of Eurotau in October 2021. This international conference in Lille, France, will bring together scientists to exchange new ideas and hypotheses on the normal and pathological roles of tau protein. Fittingly, the Rainwater Prize winners, to be announced in February 2021, will be awarded their prizes during this conference and a reception will follow.